Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe: Shanghai, China Wednesday, January 22, 2025, 14:00 Hrs [IST] Shanghai J ...

Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to ...

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...

China’s Junshi Biosciences yesterday revealed that its wholly-owned subsidiary TopAlliance Bioscience has entered into a ...

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...

Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, "Toripalimab has made significant strides in its ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Shanghai Junshi Biosciences Co., Ltd. announced that its investigational new drug application for JS212 injection has been accepted by the National Medical Products Administration. JS212 is a ...

Madrid, Jan 8 (EFE).- Spanish Prime Minister Pedro Sánchez and his cabinet will preside over the opening of a series of activities to commemorate the 50th death anniversary of dictator Francisco ...

Shanghai Junshi Biosciences Co., Ltd. announced that its drug toripalimab has received regular approval from the National Medical Products Administration for the treatment of unresectable or ...

Some have also used cheaper COVID-19 medicines from domestic companies like Henan Genuine Biotech Co., Simcere Pharmaceutical Group Ltd., and Shanghai Junshi Biosciences Co. In addition, pet owners ...